Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis

Abstract

BackgroundEosinophilic granulomatosis with polyangiitis (EGPA) is characterized by asthma-like attacks in its early stage, which is easily misdiagnosed as severe asthma. Therefore, new biomarkers for the early diagnosis of EGPA are needed, especially for differentiating the diagnosis of asthma.ObjectivesTo identify serum biomarkers that can be used for early diagnosis of EGPA and to distinguish EGPA from severe asthma.MethodData-independent acquisition (DIA) analysis was performed to identify 45 healthy controls (HC), severe asthma (S-A), and EGPA patients in a cohort to screen biomarkers for early diagnosis of EGPA and to differentiate asthma diagnosis. Subsequently, parallel reaction monitoring (PRM) analysis was applied to a validation cohort of 71 HC, S-A, and EGPA patients.ResultFour candidate biomarkers were identified from DIA and PRM analysis—i.e., serum amyloid A1 (SAA1), fibrinogen-α (FGA), and serum amyloid P component (SAP)—and were upregulated in the EGPA group, while cholesteryl ester transfer protein (CETP) was downregulated in the EGPA group compared with the S-A group. Receiver operating characteristics analysis shows that, as biomarkers for early diagnosis of EGPA, the combination of SAA1, FGA, and SAP has an area under the curve (AUC) of 0.947, a sensitivity of 82.35%, and a specificity of 100%. The combination of SAA1, FGA, SAP, and CETP as biomarkers for differential diagnosis of asthma had an AUC of 0.921, a sensitivity of 78.13%, and a specificity of 100%, which were all larger than single markers. Moreover, SAA1, FGA, and SAP were positively and CETP was negatively correlated with eosinophil count.ConclusionDIA-PRM combined analysis screened and validated four previously unexplored but potentially useful biomarkers for early diagnosis of EGPA and differential diagnosis of asthma.

In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus–Related Liver Diseases

“…For the PRM data, the intensity of each peptide was quantified by averaging the peak AUC of the top three fragment ions (b and y), and the average intensity of all the confidently identified peptides was used to calculate the protein intensity ( 35 ). For each sample, the protein with maximum intensity was used for normalization ( 36 ).…”

Comparing the effect profile of CETP in individuals of East Asian and European ancestries

“…We observed similar risk decreasing effects on asthma and CKD in European centric MR analysis of lower CETP protein concentration 5 . Lower plasma concentrations of CETP have been previously linked to asthma in non-randomized observational studies 40 . A clear biological rationale for CETP involvement in asthma or CKD is however currently absent, prohibiting a straightforward evaluation of the validity of the observed risk increasing effects in individuals of East Asian ancestry.…”

Identification of new immune subtypes of renal injury associated with anti-neutrophil cytoplasmic antibody–associated vasculitis based on integrated bioinformatics analysis

“…Among the eight key genes identified for AAV kidney injury, CSF2 is involved in the pathogenesis of several inflammatory and autoimmune diseases, and play an essential role in regulating the pro-inflammatory function of monocytes in the pathogenesis of AAV-related renal injury ( Krebs et al, 2017 ; VVilar et al, 2020 ; Rousselle et al, 2022 ). Rousselle ( Jing et al, 2022 ) found that CSF2 increased the ability of ANCA-stimulated monocytes to produce interleukin (IL)-1β and promote Th17 effector cell polarization. FGA is a major plasma protein coagulation factor in the regulation of wound healing, tissue regeneration, and the inflammatory response.…”